MedCity News: Coverage delays exacerbate inequity for Medicare beneficiaries

Aug 1, 2022, 00:00 AM

Imagine you’re diagnosed with a serious illness – bad news. But don’t worry, there’s a treatment – good news. It is clinically tested, FDA-authorized, and has been shown to have a lower risk of complications or side effects than traditional treatments.  Great news, right? Well, only if you can afford to pay for it out-of-pocket.

This frustrating scenario is soon likely to increase for many Medicare beneficiaries who could benefit from the innovative medical devices and technologies that languish in the so-called payment “no man’s land.”

Click here to see the full article on the MedCity News website.